| Value | ₹186.1 Cr |
|---|
NSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.
Ind-Swift Laboratories Ltd: key numbers
- Share price
- ₹368.20
- Market cap
- ₹3,202 Cr
- Revenue (annual)
- ₹649.1 Cr
- Net profit (annual)
- ₹43.12 Cr
- P/E (TTM)
- 38.3×Sector 48.7×
- Promoter holding
- 42.93%+0.00% QoQ
- FII holding
- 10.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ind-Swift Laboratories Ltd
All →Ind-Swift Laboratories Results Update
Ind-Swift Laboratories reported Q2 FY27 revenue up 50% to ₹234.89 crore and PAT up 3.5x to ₹31.03 crore. Operating EBITDA margin rose to 18.02%.
Ind-Swift Laboratories Q2 FY27 Results: Net Profit ₹34.2 Cr, Up 327.5% YoY
Ind-Swift Laboratories Ltd reported revenue from operations of ₹240.5 Cr (+51.6% YoY) and net profit of ₹34.2 Cr (+327.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹34.2 Cr · +327.5% YoY
Ind-Swift Laboratories Board Meeting Date
Ind-Swift Laboratories Ltd. scheduled a board meeting for October 29, 2026, to consider and approve the standalone and consolidated financial results for the quarter and half-year.
Ind-Swift Laboratories Convertible Warrants
Essix Biosciences Limited acquired 14,00,000 equity shares of Ind-Swift Laboratories Limited following the conversion of fully convertible warrants. The company disclosed this under SEBI regulations.
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14,00,000 equity shares upon conversion of warrants at Rs. 196 each. The allotment follows a previously approved preferential issue.
- Value
- ₹27.44 Cr
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14 lakh equity shares upon converting warrants for Essix Biosciences Limited, receiving ₹20.58 Crore. This increases the company's paid-up equity share capital.
- Value
- ₹20.58 Cr
Other results update announcements
All →IOL Chemicals and Pharmaceuticals Results Update
IOL Chemicals reported record quarterly revenue, EBITDA and profit for Q2 FY27 and half-year results. Standalone growth was strong, with margins expanding year-on-year.
General Insurance Corporation of India Results Update
GIC Re reported half-year ended 30 September 2026 gross premium of Rs.24,703.57 crore and profit after tax of Rs.4,377.66 crore. PAT fell 5.23% year on year.
Affle 3I Results Update
Affle 3i reports Q2 FY2027 revenue of Rs 783.6 crore, up 21.2% y-o-y, with EBITDA up 24.2%. PAT rose 17.4% to Rs 129.8 crore.
Ramkrishna Forgings Results Update
Ramkrishna Forgings' Q2 FY27 revenue rose 55% YoY to ₹1,405 crore, with PAT at ₹71 crore. Figures come from a press release highlights table.
LCC Projects Results Update
LCC Projects reported Q2 FY27 revenue of Rs 8,857 mn, up 34% year-on-year. Order book stood at Rs 81,466 mn.
Reliance Industries Results Update
Reliance Industries' media release reports Q2 FY27 consolidated revenue of ₹3,62,268 crore and EBITDA of ₹62,409 crore. Profit after tax rose 33.8% year-on-year.